Combining tetramer staining with CD103 staining revealed that NY-ESO-1-specific CD8+ cells in this tumor sample were indeed CD103+ (54), confirming that tumor-specific cells fell within the TILRM compartment in this patient. Here, CD8A is linked to neoplasm.